Erlonat 150mg Tablet 30’S

Description

Erlonat 150mg Tablet is a prescription anticancer medicine used in the treatment of certain types of cancer, most commonly non-small cell lung cancer and pancreatic cancer in specific clinical situations. it belongs to a group of medicines known as tyrosine kinase inhibitors, and it works by blocking a protein called epidermal growth factor receptor, also known as egfr. this receptor plays an important role in how cancer cells grow, divide, and survive. by inhibiting this signaling pathway, Erlonat 150mg Tablet can slow the growth of cancer cells and, in some cases, shrink tumors or help prevent the disease from progressing.

this medicine is generally used when the cancer has specific features that make it more likely to respond, especially tumors with egfr mutations in lung cancer. because its action is targeted, Erlonat 150mg Tablet is different from traditional chemotherapy, although it can still cause significant side effects and requires careful medical supervision. it is not a cure for cancer, but for the right patient it may help control the disease, improve symptoms, and extend survival. treatment decisions depend on the cancer type, stage, genetic testing results, prior treatments, and the patient’s overall condition.

Erlonat 150mg Tablet is taken by mouth and is usually part of a broader cancer treatment plan managed by an oncologist. the medicine may be used alone or in combination with other therapies depending on the diagnosis and treatment goals. since the drug can interact with many other medicines and is affected by food and stomach acidity, patients need to follow instructions closely. a healthcare professional should determine whether Erlonat 150mg Tablet is appropriate and monitor for response, toxicity, and any signs that treatment is not working as expected.

ingredients

• Erlonat 150mg Tablet: the active ingredient in this medicine. it is the component that blocks egfr activity in cancer cells, helping reduce signaling that supports tumor growth and survival. this targeted action is the reason Erlonat 150mg Tablet is used in selected cancers, especially when egfr-driven disease is present.
• tablet or capsule excipients: depending on the manufacturer, the dosage form may contain inactive ingredients such as fillers, binders, disintegrants, colorants, and coating materials. these ingredients do not treat cancer but help form the tablet, support stability, and ensure the medicine can be taken and absorbed properly. the exact excipients vary by product and should be checked if a patient has allergies or sensitivities.

key uses

• non-small cell lung cancer with egfr mutation: Erlonat 150mg Tablet is used in certain patients whose tumors have egfr mutations. these cancers may be especially responsive because the medicine directly blocks the growth signal that drives the tumor.
• locally advanced or metastatic non-small cell lung cancer: in some cases, Erlonat 150mg Tablet may be used when the cancer has spread or cannot be removed by surgery, particularly when molecular testing supports its use or when other treatment options are being considered.
• pancreatic cancer in selected patients: Erlonat 150mg Tablet may be used with other anticancer therapy in certain people with advanced pancreatic cancer. the benefit is modest and the medicine is typically chosen only in carefully selected cases under specialist supervision.
• targeted treatment based on tumor biology: the medicine is most useful when the cancer depends on egfr signaling. this makes genetic testing and tumor profiling important before starting treatment, especially in lung cancer.

how to use

Erlonat 150mg Tablet should be taken exactly as prescribed by a cancer specialist. it is taken by mouth, usually once daily, and should be taken consistently at the same time each day to help maintain steady levels in the body. it is generally recommended to take the medicine on an empty stomach, meaning at least 1 hour before or 2 hours after food, because food can increase absorption and raise the risk of side effects. swallow the tablet whole with water unless your healthcare professional tells you otherwise.

the medicine should not be taken with grapefruit or grapefruit juice, and certain acid-reducing medicines can reduce how well it works. patients should always inform their healthcare team about all prescription medicines, over-the-counter products, herbal supplements, and vitamins they use. if the tablets cannot be swallowed, ask a pharmacist or doctor for instructions rather than crushing or altering the dose on your own, because improper handling may affect safety and effectiveness. because Erlonat 150mg Tablet is a powerful anticancer medicine, monitoring blood tests and clinical response is often necessary throughout treatment.

safety information

• warnings: Erlonat 150mg Tablet can cause serious and sometimes life-threatening side effects. a major warning is lung inflammation or interstitial lung disease, which may present as new or worsening cough, shortness of breath, or fever. liver problems can also occur, so periodic liver tests may be needed. rare but severe skin reactions and gastrointestinal perforation have been reported. any sudden or severe symptom should be reported to a healthcare professional immediately.
• side effects: common side effects include rash, dry skin, itching, acne-like eruptions, diarrhea, nausea, vomiting, loss of appetite, fatigue, mouth irritation, and weakness. some people may also experience eye irritation, hair thinning, or changes in liver tests. serious side effects may include severe diarrhea causing dehydration, liver injury, severe skin blistering, breathing problems, or signs of allergic reaction such as swelling or trouble breathing.
• precautions: Erlonat 150mg Tablet should be used cautiously in people with lung disease, liver disease, dehydration, bowel disease, or a history of eye disorders. it may not be suitable for patients taking strong acid suppressors unless a specialist adjusts therapy. smoking can reduce the effectiveness of Erlonat 150mg Tablet, so patients should tell their doctor if they smoke or recently quit. older adults and people with frailty may need closer monitoring because side effects can be harder to tolerate.
• pregnancy/breastfeeding: Erlonat 150mg Tablet may harm an unborn baby and is generally not recommended during pregnancy unless the potential benefit clearly outweighs the risk. people who can become pregnant should discuss effective contraception before and during treatment and for a period after the last dose, as advised by the prescriber. breastfeeding is not recommended during treatment because it is unknown whether the drug passes into breast milk and because of potential harm to the infant.
• interactions: many interactions are clinically important. acid-reducing medicines such as proton pump inhibitors, h2 blockers, and antacids may reduce absorption and should only be used with medical guidance. strong cyp3a4 inhibitors or inducers can change Erlonat 150mg Tablet levels. warfarin and other blood thinners may increase bleeding risk and require monitoring. grapefruit products, smoking, and some herbal supplements may also affect the medicine. alcohol should be limited or avoided if it worsens stomach upset, dehydration, or liver strain.

additional information

• storage: store Erlonat 150mg Tablet at room temperature in a dry place, away from direct light, moisture, and heat. keep it in the original container tightly closed and out of reach of children and pets. do not store in the bathroom unless specifically instructed, as humidity can damage the medicine.
• missed dose: if a dose is missed, take it as soon as remembered if it is not too close to the next scheduled dose. if it is almost time for the next dose, skip the missed dose and return to the regular schedule. do not take two doses at once to make up for a missed dose unless your healthcare professional instructs you to do so.
• overdose: taking too much Erlonat 150mg Tablet may increase the risk of severe diarrhea, skin rash, nausea, vomiting, fatigue, liver problems, or serious dehydration. if an overdose is suspected, seek urgent medical help or contact poison control right away. bring the medicine package or container if possible so the healthcare team knows exactly what was taken.
• habit forming: no. Erlonat 150mg Tablet is not known to cause addiction or dependence. however, it must be taken regularly as directed to maintain its cancer-fighting effect, and stopping it without medical advice may allow the disease to worsen.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.